Biocatalytic Cascades Enable Manufacture of the Macrocyclic Peptide Enlicitid
Enlicitide decanoate (MK-0616) is a beautifully complex macrocyclic (not so small) peptide (or rather pseudo-peptide). This 1720 Da heavy beauty with 10 stereocentres is an inhibitor that blocks interaction between PCSK9 and LDL receptor and is under development at Merck for atherosclerotic cardiovascular disease. Most macrocyclic peptide drugs have to be injected. Enlicitide, however, is orally…
